Learn from the experts as they discuss challenges with implementing surveillance for hepatocellular carcinoma and emerging modalities to enhance surveillance programs.
In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveillance recommendations, barriers to implementation, emerging biomarkers in development, and unmet needs in hepatocellular carcinoma surveillance.
Presenters:
David E. Kaplan, MD, MSc
Associate Professor
Perelman School of Medicine
Chief, Hepatology Section
Division of Gastroenterology and Hepatology
University of Pennsylvania
Director of Hepatology
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania
Tamar Taddei, MD
Professor
Section of Digestive Diseases
Department of Internal Medicine
Yale School of Medicine
Chief, GI Section
VA Connecticut Healthcare System
West Haven, Connecticut